Custom Assays: ‘If You Dream It, We Can Multiplex It’

Video presentation details assay development services from MilliporeSigma With new biomarkers being published every day, fewer and fewer scientists can get exactly what they need from an off-the-shelf immunoassay kit. That’s why MilliporeSigma offers extensive custom xMAP® Technology assay design and development services, which are showcased in this 10-minute video presentation from Mike Godeny, Head […]

Read More…

METHODS Special Issue: Multiplexing Enables More Robust Surveillance for Avian Influenza

New assay developed for routine poultry monitoring In the journal Methods, scientists from Wageningen Bioveterinary Research report the development of a multiplex assay for avian influenza. The assay is built on Luminex’s xMAP® Technology, and allows for serotyping all 16 hemagglutinin (HA) and 9 neuraminidase (NA) protein subtypes simultaneously. Testing for avian influenza (AI) is […]

Read More…

The Faces of Luminex: Larry Vaughan, Facilities Operations

At Luminex, we often get caught up discussing the ins and outs of our instruments and assays, but the impact our employees have goes beyond the products we design. Where would we be without reliable facilities and high-functioning workspaces? Our Facilities team does an enormous amount of work to ensure everything from office spaces to […]

Read More…

METHODS Special Issue: New Assays to Characterize Vaccination and Infection History

Single-plex targets developed will become components for future multiplex assays Scientists in the Waterboer lab at the German Cancer Institute have developed the building blocks for a multiplex assay that will make it possible to quickly interrogate a person’s history of infection and vaccination. In a paper from Methods, the team reports developing individual assays […]

Read More…

Webinar: Protein Conformational Analysis Goes High-Throughput with xMAP Technology

Technique provides critical data for development of monoclonal antibodies and biosimilars At a 2018 xMAP® Connect user group meeting, Xing Wang, President of Array Bridge, spoke about how his team is using xMAP Technology to streamline the development of new biologics and biosimilars for pharma/biotech scientists. The 30-minute presentation focuses on protein conformational analysis (PCA), […]

Read More…

METHODS Special Issue: A Universal Protocol for Attaching Any Peptide to Dyed Magnetic Beads

A new technique eliminates the use of monoclonal antibodies and is robust enough for field use Monoclonal antibodies may soon become a thing of the past. While their high selectivity and affinity for their targets once made them the “gold standard” for detection applications, the time it takes to generate one and the variability in […]

Read More…

The Faces of Luminex: Jackie Surls, Assay Development

When Luminex decided to start a custom assay development service, we knew who would be a natural fit—Jackie Surls, a scientist with a gift for building assays. As a Development and Applications Scientist, Jackie works with a team of talented researchers to design customer-requested xMAP® Technology assays, and provides guidance to customers who need feedback […]

Read More…

Now Available: Custom Assay Services from Luminex

From full development to providing guidance, we can help you get to a functional assay—faster. The Luminex team is pleased to announce the launch of our custom development service, LuminexPLORE Lab, for assays based on xMAP® Technology. For more than 20 years, we have collaborated with customers and partners around the world in designing and […]

Read More…

METHODS Special Issue: Modifying the Luminex Workflow for Hazardous Pathogen Research

New protocol allows scientists to create assays in containment labs and perform analysis elsewhere Scientists in the UK have developed a new protocol that utilizes Luminex multiplex assays even in specialized laboratories where space for instruments is limited. A recent hazardous pathogen study has broad implications for any research team, especially those facing space limitations. […]

Read More…

Patient Perspective: How Precision Oncology Makes a Difference

Interview shows why clinical routine and advanced science need to work together It’s not often we get to hear the patient perspective, which makes this recent Mendelspod interview featuring a researcher and the husband of the cancer patient he’s helping particularly compelling. The 30-minute podcast features Christian Regenbrecht, CEO of Berlin-based CELLphenomics GmbH (better known […]

Read More…